Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

TEMPO-2: Ensayo controlado aleatorizado de TNK-tPA frente a las normas asistenciales para accidente cerebrovascular isquémico menor con oclusión demostrada.

IP: Carlos Molina Cateriano
Collaborators: -
Funding agency: University of Calgary
Funding: 45000
Reference: TEMPO-2_C.MOLINA_TRIAL-FUNDING_2016
Duration: 01/09/2016 - 31/12/2025

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 48000
Reference: 2014 SGR 686
Duration: 01/01/2014 - 31/12/2016

Malalties neurovasculars

IP: Carlos Molina Cateriano
Collaborators: Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM13/00265
Duration: 24/01/2014 - 23/01/2016

INVICTUS

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 247695.66
Reference: RD12/0014/0005
Duration: 01/01/2013 - 31/03/2017

Related news

The RECUPERA project, led by DyCare and Ephion Health in collaboration with Vall d’Hebron, Eurecat, and the Ictus Foundation, will combine AI, computer vision, and biomechanical sensors to measure patient progress and tailor exercises to their needs.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines

Related professionals

Blanca Espinosa Lopez

Blanca Espinosa Lopez

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Jesús Griñón Martínez

Jesús Griñón Martínez

Research assistant
Molecular Imaging and Therapy
Read more
Lina Fernanda Camacho Arteaga

Lina Fernanda Camacho Arteaga

Research technician
Clinical Pharmacology
Read more
Virginia Lorente Zamora

Virginia Lorente Zamora

Maintenance staff and general services
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.